Therapeutics Acquisition’s (OTCMKTS:BRLIU) quiet period is set to end on Monday, August 3rd. Therapeutics Acquisition had issued 4,000,000 shares in its public offering on June 24th. The total size of the offering was $40,000,000 based on an initial share price of $10.00. During the company’s quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any research reports for the company because of SEC regulations. Following the end of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.
BRLIU stock opened at $9.99 on Friday.
Therapeutics Acquisition Company Profile
Brilliant Acquisition Corporation operates as a blank check company. It focuses on acquiring; engaging in share exchange and share reconstruction; purchasing the assets; entering into contractual arrangements; and engaging in similar business combination with one or more businesses. The company was founded in 2019 and is based in Shanghai, China.
Featured Story: What is a Special Dividend?
Receive News & Ratings for Therapeutics Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Therapeutics Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.